Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan

Cerebral Cortex

Volumn 17, Issue 5, 2007, Pages 1206-1212

  Tunbridge, E M ^a,c   Weickert, C S ^b   Kleinman, J E ^b   Herman, M M ^b   Chen, J ^b   Kolachana, B S ^b   Harrison, P J ^a   Weinberger, D R ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

COMT; Development; Dopamine; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN FUNCTION; BRAIN MATURATION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INFANT; LIFESPAN; MALE; NEWBORN; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; AGING; CATECHOL O-METHYLTRANSFERASE; DOPAMINE; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREFRONTAL CORTEX;

EID: 34247175696     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhl032     Document Type: Article

References (41)

1. Adolfsson R, Gottfries CG, Roos BE, Winblad B. 1979. Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J Neural Transm 45:81-105.
2. Agathopolous A, Nicolopoulos D, Matsaniotis N, Papadatos C. 1971. Biochemical changes of catechol-o-methyltransferase during development of human liver. Pediatrics 47:125-128.
3. Baker K, Baldeweg T, Sivagnanasundaram S, Scambler P, Skuse D. 2005. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. Biol Psychiatry. 58:23-31.
4. Bearden CE, Jawad AF, Lynch DR, Sokol S, Kanes SJ, McDonald-McGinn DM, Saitta SC, Harris SE, Moss E, Wang PP, Zackai E, Emanuel BS, Simon TJ. 2004. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am J Psychiatry. 161:1700-1702.
5. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, Ni X, Goldman RS, Hoptman MJ, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Kunz M, Chakos M, Cooper TB, Lieberman JA. 2002. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 52:701-707.
6. Birrell JM, Brown VJ. 2000. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20:4320-4324.
7. Brust P, Walter B, Hinz R, Fuchtner F, Muller M, Steinbach J, Bauer R. 2004. Developmental changes in the activities of aromatic amino acid decarboxylase and catechol-O-methyl transferase in the porcine brain: a positron emission tomography study. Neurosci Lett. 364:159-163.
8. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, Egan MF, Kleinman JE, Weinberger DR. 2004. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75:807-821.
9. Dias R, Robbins TW, Roberts AC. 1996. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 380:69-72.
10. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917-6922.
11. Gaspirini M, Fabrizio E, Bonifati V, Meco G. 1997. Cognitive improvement during Tolcapone treatment in Parkinson's disease. J Neural Transm 104:887-894.
12. Gogos JA, Morgan M, Luine V, Ogawa S, Pfaff D, Karayiourgou M. 1998. Catechol-o-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behaviour. Proc Natl Acad Sci USA 95:9991-9996.
13. Goldman-Rakic P, Brown R. 1992. Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Dev Brain Res 4:339-349.
14. 1 receptors in prefrontal cells and circuits. Brain Res Rev 31:295-301.
15. Gothelf D, Eliez S, Thompson T, Hinard C, Penniman L, Feinstein C, Kwon H, Jin S, Jo B, Antonarakis SE, Morris MA, Reiss AL. 2005. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci 8:1500-1502.
16. Joober R, Gauthier J, Lal S, Bloom D, Lalonde P, Rouleau G, Benkelfat C, Labelle A. 2002. Catechol-o-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry 59:662-663.
17. Karoum F, Chrapusta SJ, Egan MJ. 1994. 3-methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens and striatum by a simple two-pool model. J Neurochem 63:972-979.
18. Kleinman JE, Hyde TM, Herman MM. 1995. Methodological issues in the neuropathology of mental illness. In: Bloom FE, Kupfer DJ, editors. Psychopharmcology: the fourth generation of progress. New York: Raven Press. p 859-864.
19. Kornhuber J, Konradi C, Mack-Burkhardt F, Riederer P, Heinsen H, Beckmann H. 1989. Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex. Brain Res 499:81-86.
20. Lambe EK, Krimer LS, Goldman-Rakic PS. 2000. Differential postnatal development of catecholamine and serotonin inputs to identified neurons in prefrontal cortex of rhesus monkey. J Neurosci 20:8780-8787.
21. Levitt P. 2003. Structural and functional maturation of the developing primate brain. J Pediatr 143(4 Suppl):S35-S45.
22. Lewis DA. 1997. Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology 16:385-398.
23. Lewis DA, Melchitzky DS, Sesack SR, Whitehead RE, Auh S, Sampson A. 2001. Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J Comp Neurol 432:119-136.
24. Lewis DA, Sesack SR, Levey AI, Rosenberg DR. 1998. Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development. Adv Pharmacol 42:703-706.
25. Lidow MS, Rakic P. 1992. Scheduling of monoaminergic neurotransmitter receptor expression in the primate neocortex during postnatal development. Cereb Cortex 2:401-416.
26. Luna B, Garver KE, Urban TA, Lazar NA, Sweeney JA. 2004. Maturation of cognitive processes from late childhood to adulthood. Child Dev 75:1357-1372.
27. Malholtra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D. 2002. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 159:652-654.
28. Männistö PT and Kaakkola S. 1999. Catechol-o-methyltransferase (COMT): biochemistry, molecular biology, pharmacology and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51:593-628.
29. Mattay VS, Apud JA, Rasetti R, Cayenne C, Das S, Alce G, Callicott J, Goldberg T, Egan M, Weinberger DR. 2004. Tolcapone enhances prefrontal function: an fMRI study in normal healthy volunteers. Program No. 81.15, 2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. Available from: http://www.sfn.org. 15 October 2004.
30. Palmatier MA, Pakstis AJ, Speed W, Paschou P, Goldman D, Odunsi A, Okonofua F, Kajuna S, Karoma N, Kungulilo S, Grigorenko E, Zhukova OV, Bonne-Tamir B, Lu RB, Parnas J, Kidd JR, DeMille MM, Kidd KK. 2004. COMT haplotypes suggest P2 promoter region relevance for schizophrenia. Mol Psychiatry 9:859-870.
31. Rosenberg DR, Lewis DA. 1995. Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: a tyrosine hydroxylase immunohistochemical analysis. J Comp Neurol 358:383-400.
32. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, Kotler M, Strous RD, Swartz-Vanetik M, Knobler HY, Shinar E, Beckmann JS, Yakir B, Risch N, Zak NB, Darvasi A. 2002. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71:1296-1302.
33. Shield AJ, Thomae BA, Eckloff BW, Wieben ED, Weinshilboum RM. 2003. Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Mol Psychiatry 9:151-160.
34. Shprintzen RJ, Goldberg RB, Lewin ML, Sidoti EJ, Berkman MD, Argamaso RV, Young D. 1978. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J 5:56-62.
35. Stanton HC, Cornejeo RA, Mersmann HJ, Brown LJ, Mueller RL. 1975. Ontogenesis of monoamine oxidase and catechol-O-methyl transferase in various tissues of domestic swine. Arch Int Pharmacodyn Ther 213:128-144.
36. Tunbridge EM, Bannerman DM, Sharp T, Harrison PJ. 2004. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 24:5331-5335.
37. Tunbridge EM, Harrison PJ, Weinberger DR. 2006. Catechol-o- methyltransferase, cognition and psychosis: Val158Met and beyond. Biol Psychiatry. (doi:10.1016/j.biopsych.2005.10.024).
38. Tunbridge EM, Weinberger DR, Harrison PJ. 2006. A novel protein isoform of catechol O-methyltransferase (COMT): brain expression analysis in schizophrenia and bipolar disorder and effect of Val(158)Met genotype. Mol Psychiatry 11:116-117.
39. Weinberger DR. 1987. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-999.
40. Weinberger DR, Marenco S. 2003. Schizophrenia as a neurodevelopmental disorder. In: Hirsch SR, Weinberger DR, editors. Schizophrenia. 2nd ed. MA: Blackwell Publishing, Malden, Massachusetts. p 326-348.
41. Zhu BT, Conney AH. 1998. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19:1-27.